Stay updated on Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page
- Check2 days agoChange DetectedThe site footer’s revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check22 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check30 days agoChange DetectedA notice announces NIH website transition updates and says the term “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.SummaryDifference0.5%

- Check36 days agoChange DetectedThe site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check43 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry v3.7.0 was added to the study's history, and the previous revision v3.6.6 was removed from the list.SummaryDifference0.1%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.